Author Archives: Dr. Stuart Gitlow

Commentary: DSM-5: New Addiction Terminology, Same Disease

Dr. Stuart Gitlow, President of the American Society of Addiction Medicine, argues DSM-5 changes the terminology of addiction, but the disease remains unchanged. …

Commentary: ASAM Survey to Identify Where Patient Access to Addiction Treatment is at Risk

As a growing number of states have either passed new legislation or are considering legislation limiting payment for opioid treatment, the American Society of Addiction Medicine has launched a task force focused on FDA-approved medications for opioid dependence, says their Acting President Dr. Stuart Gitlow. …

Commentary: Marijuana Legalization Takes Center Stage This Election Season

With Election Day just around the corner, voters in multiple locations will again be confronted with cannabis-related questions. Stuart Gitlow, MD, MPH, Acting President of the American Society of Addiction Medicine, says “medical marijuana” has simply been the camel’s nose under the tent, with the true goal of legalization covered up with a supposedly scientific approach. …

Commentary: Affordable Care Act Does Little to Increase Addiction Care Access

The demand for addiction treatment is high. The supply of addiction specialists is comparatively low. Yet unlike traditional economic models where money is the obstacle, in our field, the obstacle is time explains Dr. Stuart Gitlow, member of the AMA’s Council on Science & Public Health, and Acting President of the ASAM. …

Commentary: Who Should Treat Addiction?

Addiction is a complex lifelong disease which, if unaddressed, commonly results in death of the patient. Dr. Stuart Gitlow of the American Society of Addiction Medicine asks, shouldn’t we have some research to determine to whom these patients should be referred? …